Clinical trial
Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function…
NCT00013585 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00013585 |
|---|---|
| Title | Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients |
| Official title | Phase II, Placebo-Controlled, Double-Blind Study of the Selegiline Transdermal System (STS) in the Treatment of HIV-Associated Cognitive Impairment |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH Neurologic AIDS Research Consortium (NARC) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cognition Disorders, HIV Infections |
| Intervention type | Drug |
| Interventions | Selegiline hydrochloride |
| Enrollment | 127 |
| Completion | Dec 1, 2005 |
| First posted | Aug 31, 2001 |
| Last update posted | Nov 1, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: